OCH Ameliorates Bone Marrow Failure in Mice via Downregulation of T-Bet Expression

The aim of this study is to evaluate the immune mechanism of OCH in the treatment of AA (also named bone marrow failure, BMF) induced in mice. OCH at a dose of 400 μg/kg was injected intraperitoneally (I.P.) prior to the induction of BMF. Our study showed that the incidence of BMF was 100% in BMF gr...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaohong Qiao, Xiaotian Xie, Wei Shi, Jinqing Tang, Yuexia Shao, Fuxing Li
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2014/928743
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553006460043264
author Xiaohong Qiao
Xiaotian Xie
Wei Shi
Jinqing Tang
Yuexia Shao
Fuxing Li
author_facet Xiaohong Qiao
Xiaotian Xie
Wei Shi
Jinqing Tang
Yuexia Shao
Fuxing Li
author_sort Xiaohong Qiao
collection DOAJ
description The aim of this study is to evaluate the immune mechanism of OCH in the treatment of AA (also named bone marrow failure, BMF) induced in mice. OCH at a dose of 400 μg/kg was injected intraperitoneally (I.P.) prior to the induction of BMF. Our study showed that the incidence of BMF was 100% in BMF group and 13% in OCH treatment group. Significant higher level of IL-4 and lower level of IFN-γ were observed in OCH group than that in BMF group (P<0.05) as well as untreated group over BMF (P<0.05). However, there was no significant difference between OCH and untreated group. Compared with untreated, the expression level of T-bet in OCH and BMF was all significantly higher. However, T-bet expression level was lower in OCH than in BMF. In addition, OCH treatment increased NKT cell fractions of bone marrow and the colonies of CFU-GM. In conclusion, treatment of OCH prior to the induction of BMF could prevent the incidence of BMF possibly through downregulating T-bet expression leading to the transition of immune response from Th1 to Th2, suggesting OCH might be a new therapeutic approach in the treatment of BMF or AA.
format Article
id doaj-art-b6eea93f82a24b7dad0af2c55a564db4
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-b6eea93f82a24b7dad0af2c55a564db42025-02-03T05:57:12ZengWileyJournal of Immunology Research2314-88612314-71562014-01-01201410.1155/2014/928743928743OCH Ameliorates Bone Marrow Failure in Mice via Downregulation of T-Bet ExpressionXiaohong Qiao0Xiaotian Xie1Wei Shi2Jinqing Tang3Yuexia Shao4Fuxing Li5Department of Paediatrics, Tongji Hospital, Tongji University, 389 Xincun Road, Shanghai 200065, ChinaDepartment of Paediatrics, Tongji Hospital, Tongji University, 389 Xincun Road, Shanghai 200065, ChinaDepartment of Paediatrics, Tongji Hospital, Tongji University, 389 Xincun Road, Shanghai 200065, ChinaDepartment of Paediatrics, Tongji Hospital, Tongji University, 389 Xincun Road, Shanghai 200065, ChinaDepartment of Paediatrics, Tongji Hospital, Tongji University, 389 Xincun Road, Shanghai 200065, ChinaDepartment of Paediatrics, Tongji Hospital, Tongji University, 389 Xincun Road, Shanghai 200065, ChinaThe aim of this study is to evaluate the immune mechanism of OCH in the treatment of AA (also named bone marrow failure, BMF) induced in mice. OCH at a dose of 400 μg/kg was injected intraperitoneally (I.P.) prior to the induction of BMF. Our study showed that the incidence of BMF was 100% in BMF group and 13% in OCH treatment group. Significant higher level of IL-4 and lower level of IFN-γ were observed in OCH group than that in BMF group (P<0.05) as well as untreated group over BMF (P<0.05). However, there was no significant difference between OCH and untreated group. Compared with untreated, the expression level of T-bet in OCH and BMF was all significantly higher. However, T-bet expression level was lower in OCH than in BMF. In addition, OCH treatment increased NKT cell fractions of bone marrow and the colonies of CFU-GM. In conclusion, treatment of OCH prior to the induction of BMF could prevent the incidence of BMF possibly through downregulating T-bet expression leading to the transition of immune response from Th1 to Th2, suggesting OCH might be a new therapeutic approach in the treatment of BMF or AA.http://dx.doi.org/10.1155/2014/928743
spellingShingle Xiaohong Qiao
Xiaotian Xie
Wei Shi
Jinqing Tang
Yuexia Shao
Fuxing Li
OCH Ameliorates Bone Marrow Failure in Mice via Downregulation of T-Bet Expression
Journal of Immunology Research
title OCH Ameliorates Bone Marrow Failure in Mice via Downregulation of T-Bet Expression
title_full OCH Ameliorates Bone Marrow Failure in Mice via Downregulation of T-Bet Expression
title_fullStr OCH Ameliorates Bone Marrow Failure in Mice via Downregulation of T-Bet Expression
title_full_unstemmed OCH Ameliorates Bone Marrow Failure in Mice via Downregulation of T-Bet Expression
title_short OCH Ameliorates Bone Marrow Failure in Mice via Downregulation of T-Bet Expression
title_sort och ameliorates bone marrow failure in mice via downregulation of t bet expression
url http://dx.doi.org/10.1155/2014/928743
work_keys_str_mv AT xiaohongqiao ochamelioratesbonemarrowfailureinmiceviadownregulationoftbetexpression
AT xiaotianxie ochamelioratesbonemarrowfailureinmiceviadownregulationoftbetexpression
AT weishi ochamelioratesbonemarrowfailureinmiceviadownregulationoftbetexpression
AT jinqingtang ochamelioratesbonemarrowfailureinmiceviadownregulationoftbetexpression
AT yuexiashao ochamelioratesbonemarrowfailureinmiceviadownregulationoftbetexpression
AT fuxingli ochamelioratesbonemarrowfailureinmiceviadownregulationoftbetexpression